Mapping the structural transition in an amyloidogenic apolipoprotein A-I

Biochemistry

Volumn 46, Issue 34, 2007, Pages 9693-9699

  Lagerstedt, Jens O ^a   Cavigiolio, Giorgio ^c   Roberts, Linda M ^d   Hong, Hyun Seok ^b   Jin, Lee Way ^b   FitzGerald, Paul G ^a   Oda, Michael N ^c   Voss, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ELECTRON MICROSCOPY; LIPIDS; MOLECULAR STRUCTURE; MUTAGENESIS; PARAMAGNETIC RESONANCE;

AMINO ACID MUTATION; PROTOFIBRILS; SECONDARY STRUCTURES; STRUCTURAL TRANSITION;

PROTEINS;

AMINO ACID; AMYLOID; APOLIPOPROTEIN A1; APOPROTEIN; ARGININE; DYE; GLYCINE; PROTEINASE;

ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTRON SPIN RESONANCE; GENE MAPPING; GENE MUTATION; HUMAN; IN VITRO STUDY; INCUBATION TIME; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STRUCTURE; STAINING;

APOLIPOPROTEIN A-I; CIRCULAR DICHROISM; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PROTEIN CONFORMATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THIAZOLES;

EID: 34548279287     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi7005493     Document Type: Article

References (36)

1. Lewis, G. F. (2006) Determinants of plasma HDL concentrations and reverse cholesterol transport, Curr. Opin. Cardiol. 21, 345-352.
2. Oda, M. N., Forte, T. M., Ryan, R. O., and Voss, J. C. (2003) The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger, Nat. Struct. Biol. 10, 455-460.
3. Martin, D. D., Budamagunta, M. S., Ryan, R. O., Voss, J. C., and Oda, M. N. (2006) Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein, J. Biol. Chem. 281, 20418-20426.
4. Lagerstedt, J. O., Budamagunta, M. S., Oda, M. N., and Voss, J. C. (2007) EPR spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apo-AI in solution, J. Biol. Chem. 282, 9143-9149.
5. Davidson, W. S., and Silva, R. A. (2005) Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins, Curr. Opin. Lipidol. 16, 295-300.
6. Ajees, A. A., Anantharamaiah, G. M., Mishra, V. K., Hussain, M. M., and Murthy, H. M. (2006) Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases, Proc. Natl. Acad. Sci. U.S.A. 103, 2126-2131.
7. Brubaker, G., Peng, D. Q., Somerlot, B., Abdollahian, D. J., and Smith, J. D. (2006) Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity, Biochim. Biophys. Acta 1761, 64-72.
8. Silva, R. A., Hilliard, G. M., Fang, J., Macha, S., and Davidson, W. S. (2005) A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading, Biochemistry 44, 2759-2769.
9. Joy, T., Wang, J., Hahn, A., and Hegele, R. A. (2003) APOA1 related amyloidosis: a case report and literature review, Clin. Biochem. 36, 641-645.
10. Van Allen, M. W., Frohlich, J. A., and Davis, J. R. (1969) Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer, Neurology 19, 10-25.
11. Nichols, W. C., Dwulet, F. E., Liepnieks, J., and Benson, M. D. (1988) Variant apolipoprotein AI as a major constituent of a human hereditary amyloid, Biochem. Biophys. Res. Commun. 156, 762-768.
12. Nichols, W. C., Gregg, R. E., Brewer, H. B., Jr., and Benson, M. D. (1990) A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy, Genomics 8, 318-323.
13. Andreola, A., Bellotti, V., Giorgetti, S., Mangione, P., Obici, L., Stoppini, M., Torres, J., Monzani, E., Merlini, G., and Sunde, M. (2003) Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein a-I, J. Biol. Chem. 278, 2444-2451.
14. Berliner, L. J., Grunwald, J., Hankovszky, H. O., and Hideg, K. (1982) A novel reversible thiol-specific spin label: papain active site labeling and inhibition, Anal. Biochem. 119, 450-455.
15. MacDonald, R. C., MacDonald, R. I., Menco, B. P., Takeshita, K., Subbarao, N. K., and Hu, L. R. (1991) Small-volume extrusion apparatus for preparation of large, unilamellar vesicles, Biochim. Biophys. Acta 1061, 297-303.
16. Roberts, L. M., Ray, M. J., Shih, T. W., Hayden, E., Reader, M. M., and Brouillette, C. G. (1997) Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I, Biochemistry 36, 7615-7624.
17. Susi, H., and Byler, D. M. (1986) Resolution-enhanced Fourier transform infrared spectroscopy of enzymes, Methods Enzymol. 130, 290-311.
18. Tamm, L. K., and Tatulian, S. A. (1997) Infrared spectroscopy of proteins and peptides in lipid bilayers, Q. Rev. Biophys. 30, 365-429.
19. Oh, K. J., Altenbach, C, Collier, R. J., and Hubbell, W. L. (2000) Site-directed spin labeling of proteins. Applications to diphtheria toxin, Methods Mol. Biol. 145, 147-169.
20. Gillmore, J. D., Stangou, A. J., Tennent, G. A., Booth, D. R., O'Grady, J., Rela, M., Heaton, N. D., Wall, C. A., Keogh, J. A., and Hawkins, P. N. (2001) Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg, Transplantation 71, 986-992.
21. Rader, D. J., Gregg, R. E., Meng, M. S., Schaefer, J. R., Zech, L. A., Benson, M. D., and Brewer, H. B., Jr. (1992) In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis, J. Lipid Res. 33, 755-763.
22. Genschel, J., Haas, R., Propsting, M. J., and Schmidt, H. H. (1998) Apolipoprotein A-I induced amyloidosis, FEBS Lett. 430, 145-149.
23. Uversky, V. N., and Fink, A. L. (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded, Biochim. Biophys. Acta 1698, 131-153.
24. Sunde, M., and Blake, C. C. (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation, Q. Rev. Biophys. 31, 1-39.
25. Oberg, K. A., Ruysschaert, J. M., and Goormaghtigh, E. (2004) The optimization of protein secondary structure determination with infrared and circular dichroism spectra, Eur. J. Biochem. 271, 2937-2948.
26. Williams, R. W., Chang, A., Juretic, D., and Loughran, S. (1987) Secondary structure predictions and medium range interactions, Biochim. Biophys. Acta 916, 200-204.
27. Parrini, C., Taddei, N., Ramazzotti, M., Degl'Innocenti, D., Ramponi, G., Dobson, C. M., and Chiti, F. (2005) Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation, Structure (Cambridge) 13, 1143-1151.
28. Nolte, R. T., and Atkinson, D. (1992) Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism, Biophys. J. 63, 1221-1239.
29. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., and Dobson, C. M. (2002) Kinetic partitioning of protein folding and aggregation, Nat. Struct. Biol. 9, 137-143.
30. de Sousa, M. M., Vital, C, Ostler, D., Fernandes, R., Pouget-Abadie, J., Carles, D., and Saraiva, M. J. (2000) Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leul78His amyloidosis, Am. J. Pathol. 156, 1911-1917.
31. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., and Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature 418, 291.
32. Lashuel, H. A. (2005) Membrane permeabilization: a common mechanism in protein-misfolding diseases, Sci. Aging Knowledge Environ. 2005, pe28.
33. Volles, M. J., and Lansbury, P. T., Jr. (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease, Biochemistry 42, 7871-7878.
34. 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques, Eur. J. Med. Chem. 39, 573-578.
35. Naiki, H., Higuchi, K., Hosokawa, M., and Takeda, T. (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1, Anal. Biochem. 177, 244-249.
36. Kelly, J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways, Curr. Opin. Struct. Biol. 8, 101-106.